Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
Biomarkers at the crossroads of inflammation and degeneration in Parkinson’s disease: The diagnostic potential of MCP-1 and alpha-synuclein | Synapse
March 3, 2026
Biomarkers at the crossroads of inflammation and degeneration in Parkinson’s disease: The diagnostic potential of MCP-1 and alpha-synuclein
DA
D. Akramova
GR
G. Rakhimbaeva
Tashkent Institute Of Postgraduate Medical Education
TB
T. Bobomuratov
See all
Key Points
The inflammatory biomarker MCP-1 correlates significantly with degeneration in Parkinson’s disease.
MCP-1 and alpha-synuclein levels were closely monitored to assess their diagnostic capabilities.
Observational analysis focused on the relationship between inflammation and degeneration markers in the disease.
Understanding these biomarkers may highlight new pathways for diagnostics and treatments.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Akramova et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75ee0c6e9836116a29de8
https://doi.org/https://doi.org/10.1016/j.jns.2025.124207